Quick Answer
Citius Pharmaceuticals, Inc. reported Research And Development Expense of $9.16 million for the year ending 2025.
- Citius Pharmaceuticals, Inc. showed a decrease of -23.1% in Research And Development Expense from 2024 to 2025.
- This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $437.4 thousand | Q4 2014: $477.1 thousand | Q1 2015: $282.2 thousand | Q2 2015: $415.5 thousand | Q4 2015: $829.2 thousand | Q1 2016: -$200.3 thousand | Q2 2016: $381.1 thousand | Q4 2016: $1.41 million | Q1 2017: $859.9 thousand | Q2 2017: $190.6 thousand | Q4 2017: $606.5 thousand | Q1 2018: $3.44 million | Q2 2018: $778.9 thousand | Q4 2018: $2.11 million | Q1 2019: $1.70 million | Q2 2019: $2.77 million | Q4 2019: $2.66 million | Q1 2020: $2.02 million | Q2 2020: $2.64 million | Q4 2020: $6.19 million | Q1 2021: $1.55 million | Q2 2021: $2.20 million | Q4 2021: $5.46 million | Q1 2022: $3.45 million | Q2 2022: $4.89 million | Q4 2022: $3.45 million | Q1 2023: $4.73 million | Q2 2023: $3.76 million | Q4 2023: $2.62 million | Q1 2024: $3.61 million | Q2 2024: $2.76 million | Q3 2024: $33.40 million | Q4 2024: $2.13 million | Q1 2025: $3.77 million | Q2 2025: $1.62 million | Q4 2025: $1.60 million.
- Over the full 13 years of available data (2013 to 2025), Citius Pharmaceuticals, Inc.'s Research And Development Expense has grown by 1,760.6%.
- Historical annual values: Fiscal year 2025: $9.16 million | Fiscal year 2024: $11.91 million | Fiscal year 2023: $14.82 million | Fiscal year 2022: $17.66 million | Fiscal year 2021: $12.24 million | Fiscal year 2020: $8.81 million | Fiscal year 2019: $8.60 million | Fiscal year 2018: $6.56 million | Fiscal year 2017: $2.94 million | Fiscal year 2016: $2.93 million | Fiscal year 2015: $1.80 million | Fiscal year 2014: $574.00 | Fiscal year 2013: $492.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: